Absence of CHRFAM7A expression in COVID-19 patients was associated with some increased inflammatory biological markers and COVID-19 severity (lymphopenia, elevated CRP, elevated plasma viral load) with extension of the pulmonary lesions and with enhanced expression of genes of the TNF signaling pathway. The gene discussed is CRP; the disease is COVID-19.